DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) today announced that it had recently signed a long-term operating lease for a manufacturing facility in Athlone, Ireland. Abiomed expects to begin facility preparations immediately and currently anticipates that the first Impella 2.5 Cardiac Assist Device production line will be operational in approximately eighteen months.
